moray

About Moray Wright

Moray is Chief Operating Officer of Parkwalk, which he co-founded in 2009.

28 February 2017

Parkwalk closes PhoreMost follow-on investment

By |February 28th, 2017|

We are pleased to announce that Parkwalk has made an investment in Phoremost, a Cambridge University spinout, as part of a Series ‘B’ round of equity funding, alongside Amadeus Capital Partners and the University. Phoremost’s mission is to accelerate, diversify and rationalise drug discovery.

PhoreMost has developed a next-generation phenotypic screening platform called ‘SiteSeeker’ to identify […]

Congenica – Parkwalk closes investment

By |February 15th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund and the Parkwalk Technology Fund VII have invested in a $10m Series ‘B’ financing round for Congenica Limited, which spun out of the Wellcome Trust Sanger Institute and Department of Health. Congenica has developed software that enables the accurate, rapid and scalable clinical interpretation of […]

Sphere Fluidics – Parkwalk closes further funding round

By |February 15th, 2017|

We have closed a follow-on investment in Sphere Fluidics for the Opportunities Fund. This follows the UCEFs investing previously.

Sphere Fluidics is an established Life Sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services in this area.

The company was founded on IP generated by the University of Cambridge and has […]

Covatic – University of Oxford Innovation Fund III investment

By |February 15th, 2017|

Covatic is building the world’s first broadcast personalisation engine, based on world-leading IP from the University of Oxford in the field of semantic linked-data technology.  It will enable broadcasters to deliver context aware, dynamic programming tailored to the unique requirements of each audience member.

The company was founded in early 2017 by a combination of […]

Focal Point Positioning – University of Cambridge Enterprise Fund IV investment

By |February 15th, 2017|

Focal Point was founded in June 2015 with Dr Ramsey Faragher as CEO and CTO. The team had originally worked on a range of platforms seeking to improve the navigational and positioning systems on vehicles as diverse as submarines and Martian rovers. They then decided to bring that 30 years of combined knowledge to bear […]

Parkwalk wins at EISA Awards

By |February 2nd, 2017|

Parkwalk are delighted to have won both the ‘Best Investment Exit’ and ‘Best EIS Fund Manager’ categories at the EISA awards on the 1st February 2017. The awards recognised an extremely strong 2016 for Parkwalk. They were presented at the House of Lords to firms, advisers, companies and individuals that achieved outstanding performance in the context […]

17 January 2017

Polypharmakos – University of Cambridge Enterprise Fund IV investment

By |January 17th, 2017|

Cambridge and Kew join forces to find new antimicrobial substances in plants
The Parkwalk-mamanged University of Cambridge Enterprise Fund IV and Cambridge Enterprise have invested £500k in Polypharmakos Limited, a spin-out from the University of Cambridge and the Royal Botanic Gardens, Kew.
Polypharmakos’s mission is to screen natural-product sources of plant, fungal and insect origin for […]

22 December 2016

Cytora – Parkwalk closes follow-on Investment

By |December 22nd, 2016|

We are pleased to announce that the University of Cambridge Enterprise Fund IV and the Parkwalk Opportunities Fund  have closed an investment into Cytora, a geopolitical risk analytics spin-out from the University of Cambridge.

Cytora is a pioneer in event detection, whose risk analytics technology is deployed in some of the largest companies and governments in […]

Tangentix – Follow on Investment

By |December 17th, 2016|

We have recently closed a follow on investment into Tangentix for the Parkwalk Opportunities Fund.

Tangentix transforms PC gaming by offering free trial, in-game rental and purchase options.

The company’s proprietary algorithms make downloads up to 3x faster, which means that downloads can reach a wider audience, gamers can buy more games, and publishers benefit from deeper links to […]

Parkwalk and IP Group join forces in UK University Spin-Outs

By |December 16th, 2016|

IP Group plc acquires Parkwalk, the UK’s largest EIS growth fund manager focused on university spin-outs

IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, is delighted to announce that it has agreed to acquire Parkwalk Advisors Ltd (“Parkwalk”), the UK’s leading university spin-out focused EIS fund manager.

Founded […]

Parkwalk wins ‘Best Generalist’ in the Investment Week 2016/17 Tax Efficiency Awards

By |December 6th, 2016|

Parkwalk are delighted to have won the Investment Week ‘Best Generalist’ in their 2016/17 Tax Efficiency Awards.

 

Surrey NanoSystems and SBIR agree Vantablack exclusivity

By |December 5th, 2016|

Exclusive rights to the use of ultra-black Vantablack S-VIS surface coating in blackbody calibration sources has been agreed between Surrey NanoSystems and Santa Barbara Infrared (SBIR).

The unparalleled broadband absorption of Vantablack S-VIS makes it ideally suited to enhancing the performance and utility of Santa Barbara Infrared’s (SBIR) precision electro-optical instrumentation, reinforcing its leadership position […]

18 November 2016

Exonate – University of Bristol Enterprise Fund I investment

By |November 18th, 2016|

We are delighted to announce that the University of Bristol Enterprise Fund I, managed by Parkwalk, has invested in Exonate.

Exonate are developing a novel approach to modulating new vessel growth.  By controlling the balance of two contrasting forms of a protein called Vascular Endothelial Growth Factor (VEGF), they have demonstrated that they could not only treat models […]

Cambridge Touch Technologies – follow-on investment

By |November 9th, 2016|

We have recently made a follow-on investment in Cambridge Touch Technologies for the University of Cambridge Enterprise Fund IV, the Parkwalk UK Tech Fund VII and the Parkwalk Opportunities Fund  in a series ‘A’ financing round.

Cambridge Touch Technologies (CTT), a University of Cambridge start-up poised to make 3D touch technology a standard feature on smart […]

Parkwalk closes Mirriad follow-on investment

By |November 3rd, 2016|

We are pleased to announce that Parkwalk have closed a follow-on investment into Mirriad, the leading provider of NIVA (Native In-Video Advertising) services to brands and agencies looking to address the growing challenges presented by ad skipping and ad blindness. The Mirriad technology was originally developed at Surrey University,

Mirriad claims to have the most integrated set […]

28 October 2016

Proxisense – Parkwalk closes University of Oxford Innovation Fund III investment

By |October 28th, 2016|

We are delighted to announce that the University of Oxford Innovation Fund III has invested in Proxisense, an Oxford University spinout supplying specialised proximity sensors and systems to measure contamination in critical fluid systems. These products have been developed for use is for extreme and inaccessible environments.

The proximity sensor technology utilises an eddy current sensor […]

Ilika – Parkwalk investment

By |October 18th, 2016|

We are delighted to announce that the Parkwalk Opportunities EIS Fund has participated in a £6.3m funding round in Ilika, an AIM listed company which specialises in materials innovation. The company has developed unique solid state battery technology which may have applications across the Internet of Things (IoT).

Ilika spun out of the University of […]

Ceres Power – Parkwalk investment

By |October 17th, 2016|

We are delighted to announce that the Parkwalk Opportunities EIS Fund has participated in a £20m funding round in Ceres Power, the specialist provider of low cost, next generation fuel cell technology.

With technology originating from Imperial College, Ceres Power is a world leader in low cost, next generation fuel cells for use in distributed […]

20 September 2016

Xeros: Interim Results

By |September 20th, 2016|

Major progress in developing and commercialising platform technology

Xeros Technology Group plc (AIM: XSG, ‘the Group’, ‘Xeros’), the developer and provider of patented polymer bead systems with multiple commercial applications, publishes its second unaudited interim results for the six months ended 30 June 2016.

Highlights

Platform technology

·      Possess disruptive bead technology platform which can be […]

Horizon Discovery – Strong Revenue Growth and Focus on Operational Gearing Underpin Path to Profitability

By |September 20th, 2016|

Cambridge, UK, 20 September 2016: Horizon Discovery Group plc (LSE: HZD), a world leader in the application of gene editing technologies, announces its interim results for the six months ended 30 June 2016.
Highlights (including post period end):
Financial
·     Group revenue increased 19% to £10.2 million (HY15: £8.6 million)
·     Products business revenue increased 62% to £4.8 […]